|
Cabergoline
Cabergoline acts on the pituitary to block the production and release of the hormone prolactin which is over-produced when a prolactinoma is present in the gland. Prolactin in the circulation is reduced to near normal levels and there may be shrinkage of the tumour itself. Treatment is therefore associated with control of symptoms and restoration of fertility where previously affected by the condition.
Treatment is usually started at low dosage then increased gradually until the required regular (maintenance) dose has been reached. This reduces the likelihood of early side effects. The maintenance dose varies from patient to patient and depends up what is required to control your symptoms. Since Cabergoline is very long acting, it usually requires to be taken on only two days of the week in a total dose of 1 mg (occasionally up to 2 mg) per week.
|
